Skip to content

The infulunce of TEAS for patients undergoing IVF-ET aspect of ovarian response and pregnancy outcome

The infulunce of TEAS for patients undergoing IVF-ET aspect of ovarian response and pregnancy outcome

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPC-14005535
Enrollment
Unknown
Registered
2014-11-24
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

1:2Hz TEAS

Sponsors

Department of Obstetrics and Gynecology, Reproductive Medical Center, Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: tubal factor infertility; male infertility; 20-38 years old; BMI 18-31Kg/m2

Exclusion criteria

Exclusion criteria: Men and women suffered from urinary serious mental disease, acute infection, reproductive system of sexually transmitted diseases; should not be birth, cannot be done at genetic diseases of preimplantation genetic diagnosis; with drugs and other serious bad habits; ray, poison, drug any party contact teratogenic dose and in effect period; with positive urine HCG (pregnant); ovarian function abnormality, such as ovarian dysfunction (i.e., FSH more than 12miu / L, or AFC less than 7) or polycystic ovary syndrome; ovarian dysfunction, such as ovarian dysfunction (i.e., FSH more than 12miu / L, or AFC less than 7) or polycystic ovary syndrome; with pacemakers or other implanted medical electronic instruments in vivo

Design outcomes

Primary

MeasureTime frame
The growth of follicle;Gndose;time of Gn;The content of SCF in follicular fluid;rate of good quality embryos;clinical pregnancy rate;

Countries

China

Contacts

Public ContactLirong
roseli001@sina.com+86 10 82267031

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026